In these studies, we determined whether there are receptors for the an
aphylatoxin C5a (C5aR, CD88) on human mesangial cells (HMC). To prepar
e Abs to C5aR, we first synthesized an immunogenic peptide spanning re
sidues 8-32 of the molecule, and this peptide was used to immunize rab
bits. Anti-C5aR antiserum, but not preimmune serum, stained fixed and
unfixed HMC in culture. By Western blotting anti-C5aR, Abs identified
a 49.6-kDa protein in HMC. By reverse-transcription PCR, a cDNA produc
t of 558 bp was amplified corresponding to the expected size of C5aR c
DNA. A cDNA of the same size was amplified simultaneously from human P
BL, Restriction mapping of the products amplified from HMC and from PB
L gave restriction fragments of the same size, incubation of HMC with
increasing doses of C5a caused a progressive increase in the levels of
the transcription factors activator protein-1 (AP-1) and cAMP respons
e element binding protein (CREB), but C5a had no effect on the level o
f nuclear factor-kappa B (NF-kappa B), The effects of C5a on AP-1 were
concentration and time dependent and peaked after 60 min. In contrast
, the C5a metabolite C5adesArg had no significant effect on AP-1 level
s. Preincubation of HMC with rabbit anti-C5aR antiserum inhibited part
ially the effect of C5a on AP-1. However, anti-C5aR Abs alone had no a
ppreciable effects on AP-1, C5a caused a significant up-regulation of
mRNA for the early response genes c-jun and c-fos on NMC. These result
s provide evidence for the presence of C5aR in adult BMC in culture an
d indicate that, after binding to C5aR, the anaphylatoxin C5a causes s
ignificant up-regulation of certain transcription factors and early re
sponse genes.